Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease

Annals of the Rheumatic Diseases

Volumn 61, Issue 10, 2002, Pages 929-933

  Peene, I ^a   Meheus, L ^b   De Keyser, S ^b   Humbel, R ^c   Veys, E M ^a   De Keyser, Filip ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b INNOGENETICS   (Belgium)

^c Centre Hospitalier Luxembourg   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; PROTEIN; PROTEIN RA60; PROTEIN RO52; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE; HUMAN; IMMUNOASSAY; IMMUNOBLOTTING; IMMUNODIFFUSION; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ANTIBODIES, ANTINUCLEAR; AUTOANTIGENS; BIOLOGICAL MARKERS; CONNECTIVE TISSUE DISEASES; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; RECOMBINANT PROTEINS; RIBONUCLEOPROTEINS; RNA, SMALL CYTOPLASMIC;

EID: 0036785383     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.61.10.929     Document Type: Article

References (15)

1. Peene I, Meheus L, Veys E, De Keyser F. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of sera referred for ANA testing. Ann Rheum Dis 2001;60:1131-6.
2. Scofield RH, Farris AD, Horsfall AC, Harley JB. Fine specificity of the autoimmune response to the Ro/SSA and La/SSB ribonucleoproteins. Arthritis Rheum 1999;42:199-209.
3. Tan EM, Cohen AS, Fries JF, Masi AT, Mc Shane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
4. Arnett FC, Edworthy SM, Bloch DA, Mc Shane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
5. Vitali C, Bombardieri S, Moutsoupoulos M, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7.
6. Keech CL, McCluskey J, Gordon TP. Transfection and overexpression of the human 60-kDa Ro/SS-A autoantigen in HEp-2 cells. Clin Immunol Immunopathol 1994;73:146-51.
7. Peene I, Van Ael W, Vandenbossche M, Vervaet T, Veys E, De Keyser F. Sensitivity of the HEp-2000 TM substrate for the detection of anti-SSA/Ro60 antibodies. Clin Rheumatol 2000;4:291-5.
8. Pourmand N, Petterson I. The Zn2+ binding domain of the human Ro 52 kDa protein is a target for conformation dependent autoantibodies. J Autoimmunity 1998;11:11-17.
9. Meheus L, Van Venrooij WJ, Wijk A, Charles P, Tzioufas A, Meyer O, et at. Determination of the fine specificity of antinuclear antibodies in connective tissue diseases using a multiparameter line immunoassay (LIA) based on recombinant proteins. Clin Exp Rheumatol 1999;17:205-14.
10. Buyon JP, Sade SG, Chan EKL, Tan EM, Winchester R. Effective separation of the 52kDa SSA/Ro polypeptide from the 48kDa SSB/La polypeptide by altering conditions of polyacrylamide gel electrophoresis. J Immunol Methods 1990;129:207-10.
11. Rosenfeld J, Capdevielle J, Grillemot JC, Ferrara P. In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. Anal Biochem 1992;15:173-9.
12. Rutjes SA, Vree Egberts WTM, Jongen P, Van Den Hoogen F, Pruijn GJM, Van Venrooij WJ. Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy. Clin Exp Immunol 1997;109:32-40.
13. Brucato A, Buyon J, Horsfall A, Lee L, Reichlin M. Fourth International Workshop on neonatal lupus syndromes and the Ro/SSA-La/SSB system. Clin Exp Rheumatol 1999;17:130-6.
14. Buyon JP, Slade SG, Reveille JD, Hamel JC, Chan EKL. Autoantibody responses to the native 52-kD SS-A/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus and Sjögren's syndrome. J Immunol 1994;152:3675-84.
15. Itoh Y, Itoh K, Frank MB, Reichlin M. Autoantibodies to the Ro/SSA autoantigen are conformation dependent. II. Antibodies to the denaturated form of 52 kD Ro/SSA are a cross reacting subset of antibodies to the native 60 kD Ro/SSA molecule. Autoimmunity 1992;14:85-95.